13D Filing: VA Partners I, LLC and Willis Towers Watson PLC (WLTW)

Page 9 of 11

Page 9 of 11 – SEC Filing

SCHEDULE 13D
————————– ————————-
CUSIP NO. G96629103 Page 9 of 11
—————————————————————————–

Reporting Person Trade Date Buy/Sell Bought (Sold) Price/Share
—————- ———- ——– ——– ———–
ValueAct Master Fund 05/17/2017 Sell (400,000) $141.05
ValueAct Master Fund 05/18/2017 Sell (400,000) $140.11
ValueAct Master Fund 05/19/2017 Sell (200,000) $140.34
ValueAct Master Fund 05/25/2017 Sell (115,000) $145.06
ValueAct Master Fund 05/26/2017 Sell (205,000) $145.01
ValueAct Master Fund 05/30/2017 Sell (125,000) $145.05

(d) Not applicable.

(e) As of May 30, 2017 the Reporting Persons ceased to be beneficial
owners of more than five percent of Issuer?s Common Stock.

Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer

Other than as described in this Report and as previously
reported, the Reporting Persons have no understandings, arrangements,
relationships or contracts relating to the Issuer’s Common Stock which are
required to be described hereunder.

Item 7. Material to Be Filed as Exhibits

(1) Joint Filing Agreement.

SIGNATURE
After reasonable inquiry and to the best of his knowledge and
belief, the undersigned certifies that the information set forth in this
statement is true, complete and correct.

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears
below on this Schedule 13D hereby constitutes and appoints Jeffrey W. Ubben,
Bradley E. Singer, G. Mason Morfit and Allison Bennington, and each of
them, with full power to act without the other, his or its true and lawful
attorney-in-fact and agent, with full power of substitution and
resubstitution, for him or it and in his or its name, place and stead, in any
and all capacities (until revoked in writing) to sign any and all amendments
to this Schedule 13D, and to file the same, with all exhibits thereto and
other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents, and each of
them, full power and authority to do and perform each and every act and thing
requisite and necessary fully to all intents and purposes as he or it might
or could do in person, thereby ratifying and confirming all that said
attorneys-in-fact and agents or any of them, or their or his substitute or
substitutes, may lawfully do or cause to be done by virtue hereof.

Follow Willis Towers Watson Plc (NYSE:WTW)

Page 9 of 11